Christopher Gene Cummins serves as Executive at Symmetry Medical Inc., where they oversee executive responsibilities. Since joining the company, Christopher Gene Cummins has executed 7 insider transactions totaling $14.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 5, 2014 involved selling 62,707 shares valued at $581.3K.
Christopher Gene Cummins currently holds 62,707 shares of Symmetry Medical Inc. (SMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Gene Cummins has been a net seller of SMA stock. They have purchased $0 and sold $14.2K worth of shares.
Christopher Gene Cummins's most recent insider trade was on Dec 5, 2014, when they sold 62,707 shares at $9.27 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 1, 2014 | SMA | $11.4K | Payment | 1,226 | $9.28 | Discretionary |
| Jun 11, 2014 | SMA | $0 | Award | 10,000 | $N/A | Discretionary |
| Mar 5, 2014 | SMA | $14.2K | Sale | 1,325 | $10.72 | Discretionary |
| Feb 13, 2014 | SMA | $0 | Award | 14,385 | $N/A | Discretionary |
| Dec 23, 2013 | SMA | $7.7K | Payment | 835 | $9.27 | Discretionary |